Trial
NCT00697255
A Phase 2 Trial to Evaluate if Corifollitropin Alfa (Org 36286), Followed by a Low Daily Dose of hCG or Recombinant FSH Can Induce Monofollicular Growth in Women With WHO Group II Anovulatory Infertility (P05693)
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Organon and Co
Collaborators
—
Condition
Ovulation Induction
Intervention
corifollitropin alfa
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-06-17